COURTNEY RASMUSSEN: Open Payments
NPI 1003301409 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 40 payments from 15 companies in 2025. Trend: 2023 $800 · 2024 $560 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $186 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Alkermes, Inc. | 3 | $63 |
| Novo Nordisk Inc | 4 | $60 |
| PFIZER INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
Products named: VRAYLAR, QULIPTA, ARISTADA, ELIQUIS, Kerendia, VOQUEZNA, CAPLYTA, Wegovy.
Industry payments across IA — which companies pay providers there.
